CD248 deficiency promotes angiotensin II‐induced aortic lesion by attenuating receptor stability in smooth muscle cells
Clinical and Translational Medicine · 2025
DOI: 10.1002/ctm2.70352 ↗At a glance
Journal article in Clinical and Translational Medicine, 2025. Written by Tai-Tzu Hsieh and 11 co-authors. Institution: Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC. Major MEDLINE topics: Angiotensin II, Myocytes, Smooth Muscle, Aortic Aneurysm, Abdominal, Antigens, CD. Cited 2 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Science and Technology Council, Taiwan, National Health Research Institutes, Kaohsiung Medical University Hospital.
Abstract (original language)
Background
Abdominal aortic aneurysm (AAA) is characterized by progressive dilation of the abdominal aorta that has a high prevalence of death due to aortic rupture. The hallmark of AAA is severe degeneration of the aortic media with the loss of vascular smooth muscle cells (VSMCs), the main source of extracellular matrix (ECM) proteins. CD248 was originally implicated in angiogenesis and tumourigenesis, but its role in the development of AAA remains unclear.
Methods
Mice lacking CD248 ( Cd248 −/− ) were generated and evaluated for angiotensin II (Ang II) and high‐cholesterol diet feeding induced AAA. Loss‐of‐function approaches in A7r5 and C3H10T1/2 cells were used to study the involvement of CD248 in the Ang II signalling.
Results
CD248 expression was upregulated in the media and adventitia of patients and mice with aortic aneurysm. CD248 deficiency in mice exacerbates Ang II‐induced aortic lesion along with severe disruption of elastic fibres and the VSMC layer. Interestingly, while compensatory ECM deposition was found in the aortic lesion of Cd248 −/− mice, collagen I content and p38 activation were significantly attenuated. Silencing of CD248 in VSMCs downregulated mitogen‐activated protein kinase activation and ECM production. Loss of CD248 in VSMCs destabilized the membrane receptors for Ang II and platelet‐derived growth factor (PDGF), and the C‐terminal cytoplasmic domain of CD248 is apparently involved in this interaction.
Conclusions
The findings reveal that CD248 regulates the stability of the membrane receptors for Ang II and PDGF in VSMCs to transduce signals for collagen production in combating the loss of aortic wall strength during vascular remodelling. Key points CD248 reduces the occurrence of angiotensin II (Ang II)‐induced aortic lesion by facilitating collagen production to provide load‐bearing properties to the aortic wall. CD248 regulates the stability of the membrane receptors for Ang II and PDGF in VSMCs. The C‐terminal cytoplasmic tail of CD248 is a crucial domain that potentially regulates the stability of Ang II and PDGF receptors. This knowledge can enhance our understanding of how abdominal aortic aneurysm (AAA) can be treated through CD248‐mediated signaling to maintain aortic wall strength during the remodeling process.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
- Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
- Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
- Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
- Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
- Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.
ORCID profiles: Yau-Sheng Tsai
Funding
- National Science and Technology Council, Taiwan
- National Health Research Institutes
- Kaohsiung Medical University Hospital
- National Science and Technology Council
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Cite
APA
Hsieh, T. T., Ku, Y. C., Chen, C. J., Kuo, C. H., Chang, B. I., Yu, C. H., Li, Y. H., Tsai, P. J., Lin, S. W., Wu, H. L., Luo, C. Y., & Tsai, Y. S. (2025). CD248 deficiency promotes angiotensin II‐induced aortic lesion by attenuating receptor stability in smooth muscle cells. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70352
Vancouver
Hsieh TT, Ku YC, Chen CJ, Kuo CH, Chang BI, Yu CH, et al. CD248 deficiency promotes angiotensin II‐induced aortic lesion by attenuating receptor stability in smooth muscle cells. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70352
BibTeX
@article{Hsieh2025,
author = {Hsieh, Tai-Tzu and Ku, Ya-Chu and Chen, Chu-Jen and Kuo, Cheng-Hsiang and Chang, Bi-Ing and Yu, Chien-Hung and Li, Yi-Heng and Tsai, Pei-Jane and Lin, Shu-Wha and Wu, Hua-Lin and Luo, Chwan-Yau and Tsai, Yau-Sheng},
title = {CD248 deficiency promotes angiotensin II‐induced aortic lesion by attenuating receptor stability in smooth muscle cells},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70352}
}
EUVIMED